The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Two Texas-based biotechnology companies are joining forces on a mission to reverse extinction. Colossal Biosciences Inc., the Dallas-based genetics company that claimed to have brought back the dire ...